MATERIAL SAFETY DATA SHEET

Section 1: Chemical Product and Company Information

1.1 Product Identifier

Product Name: Silica Sand, Ground Silica and Fine Ground Silica Sand
and Ground Silica Sand (sold under various names): ASTM TESTING SANDS •
GLASS SAND • FILPRO® · FLINT SILICA • DM-SERIES • F-SERIES • FOUNDRY
SANDS • FJ-SERIES H-
SERIES • L-SERIES • N-SERIES • NJ SERIES • OK-SERIES • P-SERIES • T-SERIES •
hydraulic fracturing sand, all sizes • frac sand, all sizes • MIN-U-SIL® Fine
Ground Silica • MYSTIC WHITE® • #1 DRY • #1 SPECIAL • PENN SAND® •
PRO WHITE® · SILURIAN® · Q-ROK® •
SIL-CO-SIL® Ground Silica • MICROSIL® • SUPERSIL® • MASON SAND • GS SERIES •
PERSPEC
• proppant, all sizes • SHALE FRAC® - SERIES • KOSSE WHITE® • OTTAWA
WHITE® • OPTIJUMP® • LIGHTHOUSE TM.

Chemical Name or Synonym: Crystalline Silica (Quartz), Sand, Silica Sand, Flint,
Ground Silica, Fine Ground Silica, Silica Flour.

CAS No.: 14808-60-7

EINECS No.: 238-878-4

REACH Registration No.: Not applicable

1.2 Relevant Identified Uses of the Substance or Mixture and Uses

Advised Against
Product Use: (non-exhaustive list): brick, ceramics, foundry castings, glass,
grout, hydraulic, fracturing sand, frac sand, proppant, mortar, paint and
coatings, silicate chemistry, silicone, rubber, thermoset plastics.
 1.3 Details of the Supplier of the Safety Data Sheet
Manufacturer: Kaolin Techniques Pvt Ltd
Survey No 11/1,
Paddhar Village,
Bhuj,Kutch,
Gujarat,India

Contact Person Mr. Kunal Shah

Emergency Contact +919998013757

SDS Date of Preparation/Revision: 1 May 2017

Section 2: Hazards Identification

2.1 Classification of the Substance or Mixture

EU Classification (1272/2008): Specific Target Organ Toxicity Repeated Exposure Category

1

2.2 Label Elements:

DANGER
H372 Causes damage to lungs through prolonged or
repeated exposure by inhalation. P260 Do not breathe
dust.
P285 In case of inadequate ventilation wear respiratory protection.
P501 Dispose of contents/containers in accordance with local regulations.

2.3 Other Hazards: None identified

Section 3: Composition/Information on Ingredients

3.1 Substance

Component CAS Number/ Amount EU/CLP Classification

EINECS Number (1272/2008)
Crystalline Silica 14808-60-7 / 95-99.9% STOT RE 1 (H372)
(quartz) 238-878-4
Refer to Section 16 for Full Text of EU/CLP Classes and H Statements
 Section 4: First Aid Measures

4.1 Description of First Aid Measures

First Aid

Eyes: Wash immediately with plenty of water. Do not rub eyes. If irritation persists,
seek medical attention.

Skin: First aid is not required.

Ingestion: If large amounts are swallowed, get immediate medical attention.

Inhalation: First aid is not generally required. If irritation develops from

breathing dust, move the person from the overexposure and seek medical
attention if needed.

See Section 11 for more detailed information on health effects.

4.2 Most Important symptoms and effects, both acute and delayed: Particulates may
cause abrasive eye injury. Inhalation of dust may cause respiratory tract irritation.
Symptoms of exposure may include cough, sore throat, nasal congestion, sneezing,
wheezing and shortness of breath. Prolonged inhalation of respirable crystalline silica
above certain concentrations may cause lung diseases, including silicosis and lung
cancer.

4.3 Indication of any immediate medical attention and special treatment needed:
Immediate medical attention is not required.

Section 5: Fire Fighting Measures

5.1 Extinguishing Media: Use extinguishing media appropriate for surrounding fire.

5.2 Special Hazards Arising from the Substance or Mixture: Product is not
flammable, combustible or explosive.

5.3 Advice for Fire-Fighters: None required.

 Section 6: Accidental Release Measures

6.1 Personal Precautions, Protective Equipment and Emergency Procedures:

Wear appropriate protective clothing and respiratory protection. Avoid
generating airborne dust during clean-up.

6.2 Environmental Precautions: No specific precautions. Report releases to

regulatory authorities as required by local, state and federal regulations.

6.3 Methods and Material for Containment and Cleaning Up: Avoid dry sweeping. Do not
use compressed air to clean spilled sand or ground silica. Use water spraying/flushing or
ventilated or HEPA filtered vacuum cleaning system, or wet before sweeping. Dispose of in
closed containers.

6.4 Reference to Other Sections:

Refer to Section 13 for disposal information and Section 8 for protective equipment.
to Section 13 for disposal information and Section 8 for protective equipment.

Section 7: Handling and Storage

7.1 Precautions for Safe Handling: Do not generate dust. Do not breathe dust. Do not
rely on your sight to determine if dust is in the air. Respirable crystalline silica dust may
be in the air without a visible dust cloud. Use adequate exhaust ventilation and dust
collection. Maintain and test ventilation and dust collection to reduce respirable
crystalline silica dust levels to below the occupational exposure limit. Use all available
work practices to control dust exposures, such as water sprays. Practice good
housekeeping. Do not permit dust to collect on walls, floors, sills, ledges, machinery,
or equipment. Keep airborne dust concentrations below permissible exposure limits.

Where necessary to reduce exposures below the applicable exposure limit,

wear a respirator approved for silica containing dust when using, handling,
storing or disposing of this product or bag. See Section 8, for further
information on respirators. Do not alter the respirator. Do not wear a tight-
fitting respirator with facial hair such as a beard or mustache that prevents
a good face to face piece seal between the respirator and face. Maintain,
clean, and fit test respirators in accordance with applicable standards.
Wash or vacuum clothing that has become dusty.
 Participate in training, exposure monitoring, and health surveillance
programs to monitor any potential adverse health effects that may be
caused by breathing respirable crystalline silica. All applicable national and
local worker or community "right-to-know" laws and regulations should be
strictly followed.

7.2 Conditions for Safe Storage, Including any Incompatibilities: Use dust collection
to trap dust produced during loading and unloading. Keep containers closed and
store bags to avoid accidental tearing, breaking, or bursting.

7.3 Specific end use(s):

Industrial uses: Various commercial and industrial applications.
Professional uses: Various commercial and industrial applications.

Section 8: Exposure Controls / Personal Protection

8.1 Control Parameters:

Chemical
ACGIH TLV EU IOEL UK OEL DFG MK France
Name
0.1 mg/m3 0.1 mg/m3
Crystalline 0.025 mg/m3 TWA None None
TWA TWA
Silica (quartz) (respirable dust) Established Established
(respirable (respirable)

Where not listed above, refer to local regulations for applicable exposure limits

DNEL: None established

PNEC: None established

If crystalline silica (quartz) is heated to more than 870°C, quartz can change
to a form of crystalline silica known as tridymite; if crystalline silica (quartz)
is heated to more than 1470°C, quartz can change to a form of crystalline
silica known as cristobalite. In some countries, the exposure limits for
crystalline silica as tridymite or cristobalite is different than the exposure
limit for crystalline silica (quartz).

8.2 Exposure Controls:

Recommended Monitoring Procedures: Collection on filters and analysis by x-ray
diffraction. Size selective sampling is recommended.
Appropriate engineering controls: Use adequate general or local exhaust
ventilation to maintain concentrations in the workplace below the
applicable exposure limits listed above.

Personal Protective Measurers

Respiratory Protection: If it is not possible to reduce airborne exposure

levels to below the applicable limit with ventilation, follow local regulations
to assist you in selecting respirators that will reduce personal exposures to
below the limits. Refer to EN 529 or member state-specific guidance on use
and selection of respiratory protection.

Eye Protection: Safety glasses with side shields or goggles recommended if

eye contact is anticipated (EN 166)

Skin Protection: Maintain good industrial hygiene. Protection

recommended for workers suffering from dermatitis or sensitive skin.

Other Protection: None known.

Section 9: Physical and Chemical Properties

9.1 Information on basic Physical and Chemical Properties

Appearance and Odor: White or tan sand: granular, crushed or ground to a powder.

Solubility in Water: Insoluble Boiling Point: 4046°F/2230°C

Odor Threshold: Not determined Partition Coefficient: Not applicable
pH: 6-8 Melting Point: 3110°F/1710°C
Specific Gravity: 2.65 Vapor Density: Not applicable
Evaporation Rate: Not applicable Vapor Pressure: Not applicable
Flammability(solid/ga Not applicable Flash Point: Not applicable
s):
Explosive Limits: Not applicable Autoignition Not determined
Temperature:
Decomposition Not determined Viscosity: Not applicable
Temperature:
Explosive Properties: Not applicable Oxidizing Properties: Not applicable
 Section 10: Stability and Reactivity

10.1 Reactivity: Not reactive under normal conditions of use.

10.2 Chemical Stability: Stable.

10.3 Possibility of Hazardous Reactions: Contact with powerful oxidizing agents, such as
fluorine, chlorine trifluoride and oxygen difluoride, may cause fires.

10.4 Conditions to Avoid: Avoid generation of dust in handling and use.

10.5 Incompatible Materials: Powerful oxidizers such as fluorine, chlorine trifluoride,

and oxygen difluoride and hydrofluoric acid.

10.6 Hazardous Decomposition Products: Silica will dissolve in hydrofluoric acid and
produce a corrosive gas, silicon tetrafluoride.

10.7 , silicon tetrafluoride.

Section 11: Toxicological Information

11.1 Information on Toxicological Effects:

Acute effects of exposure:

Inhalation: Inhalation of dust may cause respiratory tract irritation. Symptoms of
exposure may include
cough, sore throat, nasal congestion, sneezing, wheezing and shortness of breath.
Ingestion: Ingestion in an unlikely route of exposure. If dust is swallowed, it
may irritate the mouth and throat.
Skin contact: No adverse effects are expected.
Eye contact: Particulates may cause abrasive injury.

Chronic effects: Prolonged inhalation of respirable crystalline silica may

cause lung disease, silicosis, lung cancer and other effects as indicated
below.
The method of exposure that can lead to the adverse health effects described below is
inhalation.
A. SILICOSIS
The major concern is silicosis, caused by the inhalation of respirable
crystalline silica dust. Silicosis can exist in several forms, chronic (or
ordinary), accelerated, or acute.

Chronic or Ordinary Silicosis is the most common form of silicosis, and can
occur after many years (10 to 20 or more) of prolonged repeated inhalation
of relatively low levels of airborne respirable crystalline silica dust. It is
further defined as either simple or complicated silicosis. Simple silicosis is
characterized by lung lesions (shown as radiographic opacities) less than 1
centimeter in diameter, primarily in the upper lung zones. Often, simple
silicosis is not associated with symptoms, detectable changes in lung
function or disability. Simple silicosis may be progressive and may develop
into complicated silicosis or progressive massive fibrosis (PMF).
Complicated silicosis or PMF is characterized by lung lesions (shown as
radiographic opacities) greater than 1 centimeter in diameter. Complicated
silicosis or PMF symptoms, if present, are shortness of breath and cough.
Complicated silicosis or PMF may be associated with decreased lung
function and may be disabling. Advanced complicated silicosis or PMF may
lead to death. Advanced complicated silicosis or PMF can result in heart
disease secondary to the lung disease (cor pumonale).

Accelerated Silicosis can occur with prolonged repeated inhalation of high

concentrations of respirable crystalline silica over a relatively short period;
the lung lesions can appear within five (5) years of initial exposure.
Progression can be rapid. Accelerated silicosis is similar to chronic or
ordinary silicosis, except that lung lesions appear earlier and progression is
more rapid.

Acute Silicosis can occur after the repeated inhalation of very high
concentrations of respirable crystalline silica over a short time period,
sometimes as short as a few months. The symptoms of acute silicosis
include progressive shortness of breath, fever, cough, weakness and
weight loss. Acute silicosis is fatal.
B. CANCER

IARC - The International Agency for Research on Cancer ("IARC") concluded

that “crystalline silica in the form of quartz or cristobalite dust is
carcinogenic to humans (Group 1)”. For further information on the IARC
evaluation, see IARC Monographs on the Evaluation of Carcinogenic Risks
to Humans, Volume 100C,"A Review of Human Carcinogens: Arsenic,
Metals, Fibres and Dusts " (2011).

C. AUTOIMMUNE DISEASES
Several studies have reported excess cases of several autoimmune disorders, --
scleroderma, systemic lupus erythematosus, rheumatoid arthritis -- among silica-
exposed workers.

D. TUBERCULOSIS
Individuals with silicosis are at increased risk to develop pulmonary
tuberculosis, if exposed to tuberculosis bacteria. Individuals with chronic
silicosis have a three-fold higher risk of contracting tuberculosis than
similar individuals without silicosis.

E. KIDNEY DISEASE
Several studies have reported excess cases of kidney diseases, including
end stage renal disease, among silica-exposed workers. For additional
information on the subject, the following may be consulted: "Kidney
Disease and Silicosis”, Nephron, Volume 85, pp. 14-19 (2000).

F. NON-MALIGNANT RESPIRATORY DISEASES

The reader is referred to Section 3.5 of the NIOSH Special Hazard Review
cited below for information concerning the association between exposure
to crystalline silica and chronic bronchitis, emphysema and small airways
disease. There are studies that disclose an association between dusts found
in various mining occupations and non-malignant respiratory diseases,
particularly among smokers. It is unclear whether the observed
associations exist only with underlying silicosis, only among smokers, or
result from exposure to mineral dusts generally (independent of the
presence or absence of crystalline silica, or the level of crystalline silica in
the dust).
Sources of information:
The NIOSH Hazard Review - Occupational Effects of Occupational Exposure to
Respirable Crystalline Silica published in April 2002 summarizes and discusses the
medical and epidemiological literature on the health risks and diseases associated
with occupational exposures to respirable crystalline
silica. The NIOSH Hazard Review is available from NIOSH - Publications Dissemination, 4676
Columbia

Parkway, Cincinnati, OH 45226, or through the NIOSH web site,

www.cdc.gov/niosh/topics/silica, then click on the link “NIOSH Hazard
Review: Health Effects of Occupational Exposure to Respirable Crystalline
Silica”.

For a more recent review of the health effects of respirable crystalline

silica, the reader may consult Fishman’s Pulmonary Diseases and Disorders,
Fourth Edition, Chapter 57. “Coal Workers’ Lung Diseases and Silicosis”.

Acute Toxicity Values:

Crystalline Silica (quartz): LD50 oral rat >22,500 mg/kg

Skin corrosion/irritation: Does not meet the criteria

for classification. Eye damage/ irritation: Does not

meet the criteria for classification. Respiratory

Irritation: Does not meet the criteria for

classification.

Skin Sensitization: Does not meet the criteria for

classification. Respiratory Sensitization: Does not

meet the criteria for classification. Germ Cell

Mutagenicity: Does not meet the criteria for

classification. Carcinogenicity: See above under

CANCER.
Developmental / Reproductive Toxicity: No specific data is available, however, there is no
evidence that silica exposure has any effect on reproduction.

Specific Target Organ Toxicity (Single Exposure): Does not meet the criteria for classification.

Specific Target Organ Toxicity (Repeated Exposure): See above.

Aspiration Toxicity: Not an aspiration hazard.

Toxicity: Not an aspiration hazard.

Section 12: Ecological Information

12.1 Toxicity: Crystalline silica (quartz) is not known to be ecotoxic.

12.2 Persistence and degradability: Silica is not degradable.

12.3 Bio accumulative Potential: Silica is not bio accumulative.

12.4 Mobility in Soil: Silica is not mobile in soil.

12.5 Results of PBT and vPvB Assessment: None required.

12.6 Other Adverse Effects: No data available.

Section 13: Disposal Considerations

13.1 Waste Treatment Methods:

Dispose in accordance with all applicable local, state/provincial and national/
federal regulations in light of the contamination present. Local regulations may
be more stringent than regional and national requirements. It is the
responsibility of the waste generator to determine the toxicity and physical
characteristics of the material to determine the proper waste identification and
disposal in compliance with applicable regulations.
 Section 14: Transport Information

14.1 UN 14.2 UN Proper Shipping Name 14.3 14.4 14.5

Number Hazard Packing Environmental
Class(s) Group Hazards
US DOT None Not Regulated None None
CANADIAN None Not Regulated None None
TDG
EU None Not Regulated None None
ADR/RID
IMDG None Not Regulated None None
IATA/ICAO None Not Regulated None None

14.6 Special Precautions for User: None identified

14.7 Transport in Bulk According to Annex III MARPOL 73/78 and the IBC Code: Not
applicable. Transported in packaged form only.

Section 15: Regulatory Information

15.1 Safety, Health and Environmental Regulations/Legislation Specific for the Substance or
Mixture

INTERNATIONAL INVENTORIES

US EPA TSCA Inventory: All of the components of this product are listed on the EPA
TSCA inventory.

Canadian Domestic Substances List: U. S. Silica Company products, as

naturally occurring substances, are on the Canadian DSL.

Australian Inventory of Chemical Substances (AICS): All of the

components of this product are listed on the AICS inventory or
exempt from notification requirements.
China: Silica is listed on the IECSC inventory or exempt from notification
requirements.

Korea Existing Chemicals Inventory (KECI) (set up under the Toxic

Chemical Control Law): Listed on the ECL with registry number
9212-5667.

Japan Ministry of International Trade and Industry (MITI): All of the

components of this product are existing chemical substances as
defined in the Chemical Substance Control Law Registry

Number 1-548.

New Zealand: Silica is listed on the HSNO inventory or exempt from notification
requirements.

Philippines Inventory of Chemicals and Chemical Substances (PICCS): Listed for PICCS.

Taiwan: Silica is listed on the CSNN inventory or exempt from notification

requirements.

Section 16: Other Information

GHS Classes and Hazard Statements for Reference (See Sections 3):
STOT-RE Cat 1 - Specific Target Organ Toxicity (Repeated
Exposure) Category 1 H372 Causes damage to lungs
through prolonged or repeated exposure by inhalation

Effective Date: 1 May 2017

Supersedes Date: 23 July 2014